Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Aspira Pathlab & Diagnostics Ltd

₹ 106 0.86%
10 Jul 1:20 p.m.
aspiradiagnostics.com BSE: 540788
About

Incorporated in 1973, Aspira Pathlab & Diagnostics Ltd is in the business of pathology and related healthcare services[1]

Key Points

Business Overview:[1]
Company is in the business of running, owning, managing and administering Diagnostics Centers in Mumbai.

Website BSE
  • Market Cap ₹ 109 Cr.
  • Current Price ₹ 106
  • High / Low ₹ 136 / 49.0
  • Stock P/E 2,182
  • Book Value ₹ 11.9
  • Dividend Yield 0.00 %
  • ROCE 2.84 %
  • ROE 0.51 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Debtor days have improved from 42.1 to 25.3 days.

Cons

  • Stock is trading at 8.96 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Promoter holding is low: 18.4%
  • Company has a low return on equity of -2.31% over last 3 years.
  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.0.52 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
3.41 2.60 3.32 3.46 3.82 4.64 6.18 5.41 5.78 5.25 8.09 5.12 6.52
3.26 2.92 3.68 3.83 3.95 4.29 4.83 4.65 4.73 4.44 5.90 6.33 6.85
Operating Profit 0.15 -0.32 -0.36 -0.37 -0.13 0.35 1.35 0.76 1.05 0.81 2.19 -1.21 -0.33
OPM % 4.40% -12.31% -10.84% -10.69% -3.40% 7.54% 21.84% 14.05% 18.17% 15.43% 27.07% -23.63% -5.06%
0.07 0.10 0.14 0.10 0.08 0.09 0.08 0.09 0.13 0.11 0.14 0.13 0.14
Interest 0.10 0.10 0.10 0.09 0.08 0.08 0.08 0.09 0.09 0.09 0.10 0.10 0.10
Depreciation 0.38 0.39 0.39 0.38 0.38 0.38 0.36 0.39 0.37 0.37 0.40 0.38 0.40
Profit before tax -0.26 -0.71 -0.71 -0.74 -0.51 -0.02 0.99 0.37 0.72 0.46 1.83 -1.56 -0.69
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-0.26 -0.72 -0.71 -0.74 -0.50 -0.02 0.99 0.38 0.72 0.47 1.84 -1.56 -0.69
EPS in Rs -0.25 -0.70 -0.69 -0.72 -0.49 -0.02 0.96 0.37 0.70 0.46 1.79 -1.52 -0.67
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0.00 0.00 0.76 4.36 7.64 8.42 15.21 19.54 14.46 13.20 22.00 24.98
0.14 0.23 3.34 8.24 10.88 10.25 11.69 13.16 12.86 14.38 18.44 23.52
Operating Profit -0.14 -0.23 -2.58 -3.88 -3.24 -1.83 3.52 6.38 1.60 -1.18 3.56 1.46
OPM % -339.47% -88.99% -42.41% -21.73% 23.14% 32.65% 11.07% -8.94% 16.18% 5.84%
0.21 0.32 0.31 0.22 0.25 0.29 0.20 0.09 0.32 0.42 0.36 0.52
Interest 0.00 0.05 0.26 0.80 0.96 1.01 0.89 0.37 0.42 0.37 0.35 0.39
Depreciation 0.00 0.00 0.20 1.12 1.23 1.66 1.44 1.64 1.59 1.54 1.49 1.54
Profit before tax 0.07 0.04 -2.73 -5.58 -5.18 -4.21 1.39 4.46 -0.09 -2.67 2.08 0.05
Tax % 57.14% 25.00% 0.00% 0.00% 0.00% 0.71% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.02 0.03 -2.72 -5.58 -5.18 -4.24 1.38 4.46 -0.09 -2.67 2.07 0.05
EPS in Rs 0.09 0.13 -5.24 -10.75 -6.32 -4.56 1.34 4.33 -0.09 -2.59 2.01 0.05
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 10%
3 Years: 20%
TTM: 14%
Compounded Profit Growth
10 Years: 5%
5 Years: -49%
3 Years: 37%
TTM: -98%
Stock Price CAGR
10 Years: %
5 Years: 26%
3 Years: 58%
1 Year: 96%
Return on Equity
10 Years: %
5 Years: 11%
3 Years: -2%
Last Year: 1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 2.25 2.25 5.19 5.19 8.19 9.29 10.29 10.29 10.29 10.29 10.29 10.29
Reserves 1.36 1.39 0.72 -4.86 -7.93 -10.42 -6.91 -2.43 -2.47 -5.08 -3.01 1.94
0.00 2.62 7.29 11.36 12.52 13.80 7.01 8.85 8.24 7.71 8.13 3.32
0.21 0.03 1.66 0.84 2.02 1.67 1.39 1.42 1.28 1.79 2.11 2.96
Total Liabilities 3.82 6.29 14.86 12.53 14.80 14.34 11.78 18.13 17.34 14.71 17.52 18.51
0.00 0.04 7.79 7.91 8.90 8.70 7.75 9.57 8.01 6.79 6.53 7.20
CWIP 0.00 0.00 0.25 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.13 0.00
3.82 6.25 6.82 4.62 5.90 5.64 4.03 8.56 9.33 7.92 10.86 11.31
Total Assets 3.82 6.29 14.86 12.53 14.80 14.34 11.78 18.13 17.34 14.71 17.52 18.51

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-0.37 -1.29 -4.81 -3.39 -1.87 5.67 2.03 -0.01 1.05 1.88 1.45
-0.02 -10.14 -0.77 -1.97 0.24 -0.09 -0.51 0.16 0.14 0.07 -0.80
2.64 8.91 6.52 3.35 1.27 -2.17 -1.35 -0.94 -0.95 -0.99 -1.14
Net Cash Flow 2.25 -2.52 0.94 -2.00 -0.35 3.41 0.17 -0.79 0.24 0.95 -0.49
Free Cash Flow -0.41 -8.41 -5.81 -3.90 -1.92 5.37 1.42 -0.15 0.79 1.71 0.75
CFO/OP 139% 50% 124% 105% 101% 161% 32% -1% -89% 53% 99%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 43.22 29.30 38.22 26.01 40.80 83.87 59.07 61.94 38.99 25.28
Inventory Days 312.86 103.88 45.22 51.36 51.35 46.50 58.40 62.69 50.31 56.53
Days Payable 730.00 64.58 46.84 73.37 91.60 70.91 51.10 101.70 73.00 92.06
Cash Conversion Cycle -373.92 68.61 36.60 4.00 0.55 59.46 66.37 22.93 16.30 -10.25
Working Capital Days -2,199.61 -5.86 -96.03 -127.01 16.32 69.30 48.72 25.16 14.10 -4.24
ROCE % 1.82% -25.39% -38.41% -34.49% -25.15% 19.77% 35.65% 2.01% -15.87% 17.37% 2.84%

Insights

In beta
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Permanent Employees
employees

Log in to view insights

Please log in to see hidden values.

Login
B2B Revenue Share
% of revenue

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

9 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
19.37% 18.90% 18.90% 18.72% 18.72% 18.55% 18.55% 18.39% 18.39% 18.39% 18.39% 18.39%
80.64% 81.10% 81.10% 81.29% 81.28% 81.46% 81.46% 81.62% 81.62% 81.61% 81.61% 81.61%
No. of Shareholders 1,3711,4061,3511,5121,6951,7061,5931,7411,7701,7551,7841,769

Documents

Announcements

Annual reports